EGG

Enigmatig Ltd

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 0%
Negative

Neutral
GlobeNewsWire
3 months ago
Enigmatig Signs MOU with TVA Capital to Empower SMEs for Sustainable Growth in Asia Pacific
Strategic partnership marks Enigmatig's first move following its NYSE listing, reinforcing its commitment to sustainable growth and long-term value creation in the region Strategic partnership marks Enigmatig's first move following its NYSE listing, reinforcing its commitment to sustainable growth and long-term value creation in the region
Enigmatig Signs MOU with TVA Capital to Empower SMEs for Sustainable Growth in Asia Pacific
Neutral
GlobeNewsWire
4 months ago
Enigmatig Celebrates NYSE American Listing with Bell Ringing Ceremony, Signaling Next Phase of Global Growth
NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Enigmatig Limited (NYSE American: EGG) (“Enigmatig” or the “Company”), a global business enabler empowering small and medium-sized enterprises (SMEs) to scale across borders, today rang the Closing Bell at the New York Stock Exchange (“NYSE”) to mark its recent listing and reaffirm its mission to power the global ambitions of bold, forward-thinking businesses.
Enigmatig Celebrates NYSE American Listing with Bell Ringing Ceremony, Signaling Next Phase of Global Growth
Positive
Seeking Alpha
6 months ago
U.S. IPO Weekly Recap: Sizable Precision Medicine And Insurance IPOs Raise A Combined $902 Million
A handful of IPOs and blank checks priced in the short holiday week, led by two sizable issuers. Two smaller IPOs also priced this past week. One IPO is currently scheduled to list in the week ahead, although some small names may also join the calendar throughout the week.
U.S. IPO Weekly Recap: Sizable Precision Medicine And Insurance IPOs Raise A Combined $902 Million
Neutral
GlobeNewsWire
6 months ago
Enigmatig Limited Announces Closing of US$15 Million Initial Public Offering, Including Exercise of Over-allotment Option
NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Enigmatig Limited (NYSE American: EGG) ("Enigmatig" or the "Company"), an international consultancy firm providing one-stop cross-border licensing solutions and related services, today announced that it has completed its previously announced initial public offering (the "IPO") and the sole bookrunner, on behalf of the underwriters, has exercised the over-allotment opinion in part to purchase an additional 160,000 shares of common stock from the Company at the IPO price of US$5.00 per share.
Enigmatig Limited Announces Closing of US$15 Million Initial Public Offering, Including Exercise of Over-allotment Option